HIGHLIGHTS
- who: Ammara Muazzam and colleagues from the University of Manchester, Manchester , PL, UK have published the paper: A Novel Blood Proteomic Signature for Prostate Cancer, in the Journal: Cancers Cancers 2023, 2023, 15, 15, 1051 1051 of /2023/
- what: Taken together this study provides a proteomic signature complementary to PSA for the diagnosis of patients with localised cancer with the further potential for assessing risk of future development of Data are available via ProteomeXchange with identifier PXD025484. The authors identify biomarkers that could improve the diagnosis of PCa by leveraging SWATH-MS as a state . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.